Yuko Motooka-halseth, FNP | |
1801 E March Ln Ste D470, Stockton, CA 95210-6677 | |
(209) 507-7027 | |
(209) 762-6808 |
Full Name | Yuko Motooka-halseth |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 1801 E March Ln Ste D470, Stockton, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003425950 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 95014939 (California) | Primary |
Entity Name | Community Medical Centers, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588729180 PECOS PAC ID: 8426968520 Enrollment ID: O20101027000870 |
News Archive
Vanderbilt University hopes to enroll about 400 women in a national study to evaluate the effectiveness of a new model of group prenatal care designed to improve the health and well-being of mothers and babies during pregnancy, birth and infancy.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
GE Healthcare has successfully linked its electronic medical records (EMR) solution with several non-GE inpatient systems, providing a single view of the patient record that will go beyond the requirements of meaningful use. The interoperability solution is set to debut at beta sites Capital Region Healthcare (N.H.) and Decatur Memorial Hospital (Ill.) in early 2011 with general availability expected later that year.
Personal Genome Diagnostics, Inc., a provider of advanced cancer genome analysis and testing services, today announced the launch of its ImmunoSelect-R service designed to identify mutant neoantigens and support development of immuno-oncology cancer therapies.
When treated at the same medical centers as Caucasians, they fare just as well. These are the results of a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Yuko Motooka-halseth, FNP 7210 Murray Dr, Stockton, CA 95210-3339 Ph: (209) 373-2800 | Yuko Motooka-halseth, FNP 1801 E March Ln Ste D470, Stockton, CA 95210-6677 Ph: (209) 507-7027 |
News Archive
Vanderbilt University hopes to enroll about 400 women in a national study to evaluate the effectiveness of a new model of group prenatal care designed to improve the health and well-being of mothers and babies during pregnancy, birth and infancy.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
GE Healthcare has successfully linked its electronic medical records (EMR) solution with several non-GE inpatient systems, providing a single view of the patient record that will go beyond the requirements of meaningful use. The interoperability solution is set to debut at beta sites Capital Region Healthcare (N.H.) and Decatur Memorial Hospital (Ill.) in early 2011 with general availability expected later that year.
Personal Genome Diagnostics, Inc., a provider of advanced cancer genome analysis and testing services, today announced the launch of its ImmunoSelect-R service designed to identify mutant neoantigens and support development of immuno-oncology cancer therapies.
When treated at the same medical centers as Caucasians, they fare just as well. These are the results of a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
› Verified 5 days ago
Harmanpreet Kaur, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 415 E Harding Way, Stockton, CA 95204 Phone: 209-944-5750 | |
Rex Ambatali Jr., FNP-C, CVNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2633 Pacific Ave, Stockton, CA 95204 Phone: 209-944-5530 | |
Mrs. Deborah Kay Hastie, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 73 W March Lane, Suite F, Stockton, CA 95207 Phone: 209-952-5555 Fax: 209-952-1907 | |
Mrs. Ketty Ukpong Uweh, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 644 E Harding Way Ste B, Stockton, CA 95204 Phone: 209-244-9191 Fax: 209-244-9190 | |
Dr. Joan S Rubinger, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2488 N California St, C/o R Winter Md, Stockton, CA 95204 Phone: 209-518-5051 | |
Lisa Hansen, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 89 W March Ln, Suite #1, Stockton, CA 95207 Phone: 209-478-2622 Fax: 209-870-2754 |